Animal euthanasia has increased at pet shelters nationwide. How does OKC's shelter fare?
Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Telesis Bio, Inc. - Common Stock (NQ: TBIO )

3.640 -0.040 (-1.09%)
Streaming Delayed Price Updated: 10:17 AM EDT, Aug 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telesis Bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Telesis Bio: Q1 Earnings Insights
Via Benzinga
Telesis Bio Earnings Perspective: Return On Capital Employed
Via Benzinga
Telesis Bio Appoints William J. Kullback Chief Financial Officer
From Telesis Bio
Via GlobeNewswire
Pfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: Analyst
KeyBanc Capital Markets analyst Paul Knight downgraded Telesis Bio, Inc. (NASDAQ: TBIO) to  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Telesis Bio Reports Second Quarter 2023 Financial Results
-- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year 
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Telesis Bio to Present at Jefferies Healthcare Conference 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
From Telesis Bio
Via GlobeNewswire
Telesis Bio Secures Financing of $28.0 Million
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at SynBioBeta 2023
Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications 
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Telesis Bio Reports First Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.